SQUAREX LLC has a total of 12 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CISTRON BIOTECHNOLOGY INC, VIRACTA THERAPEUTICS INC and FORTE SUBSIDIARY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Mctavish Hugh | 12 |
#2 | Horn Thomas Dag | 3 |
#3 | Johnson Sandra Marchese | 3 |
#4 | Horn Thomas | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020055382A1 | Topical immunosensitizers to treat viral and fungal infections | |
AU2016225025A1 | Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection |